BZAM Ltd BZAMF

Healthcare Cannabis

BZAM Ltd. is a Canadian cannabis producer with a focus on branded consumer goods. Its portfolio includes core brands, such as BZAM, TGOD, ness, Highly Dutch Organic, TABLE TOP, as well as partner brands Jeeter, Cookies, Sherbinskis, Dunn Cannabis, FRESH and Wyld. It operates facilities in British Columbia (BC), Alberta (AB), Ontario and Quebec, as well as retail stores in Regina, Saskatchewan. The Company’s subsidiaries, The Green Organic Dutchman Ltd. (TGOD), BZAM Management Inc., Folium Life Science Inc. and BZAM Cannabis Corp., are licensed producers and hold licenses to produce cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts and edible cannabis and sell such cannabis products within Canada to provincially authorized retailers or distributors and federally licensed entities. Its product portfolio includes categories, such as Infused, Multi-packs, Edibles, Organic, and Craft.

GREY:BZAMF - Post by User

BZAM Ltd > PROGNOSIS ANYONE ?

<< Previous

Bullboard Posts

Next >>

Comment by SamRothsteinon Nov 25, 2021 4:39pm

357 Views

Post# 34166549

RE:PROGNOSIS ANYONE ?

I feel really bad for everyone that is underwater here. Been there many times and it sucks. And I have no idea if TGOD climbs back enough to make most current shareholders whole. But I do think that the risk/reward at current sp is decent because I think there is decent chance they get bought out. I was in Supreme Cannabis when Canopy bought them and most of the shareholders were so pissed because the buyout didn't make them whole (although the shares they now own in Canopy might eventually). But I was lucky because I got in near the bottom so it was profitable for me. I think this might become similar situation, and they get bought out for decent premium to current sp. There is a worse scenario though, which is that they do a restructuring that involves a haircut for existing shareholders. Their new debt covenants require positive ETIBDA by early 2022 (i forget exact date). So did they agree to that because they had no alternative? Or do they actually think they can get there in time? I'm not sure, but I do think they will now be compelled to be laser focused on cutting costs (which have been way too little and too late) and hopefully with recent acquisitions, and bringing in outside sales force pros they can boost earnings. So above average risk and above average reward here. And stock might drift even lower as the latest earnings are digested and all the traders are back on Monday.